---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-25-017492"
form_type: "8-K"
ticker: "MDCX"
cik: "0001997296"
company_name: "Medicus Pharma Ltd."
filed_at: "2025-12-30T23:59:59+00:00"
generated_at: "2026-05-16T12:02:17.495258+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Medicus Pharma enters up to $15.35M ATM equity distribution agreement with Maxim and Yorkville

## Summary
- ATM program for aggregate offering of up to $15,349,674 of common shares via Maxim Group and Yorkville Securities.
- Commission of 3.0% of gross sales; agents also reimbursed for reasonable expenses.
- Sales will be at-the-market on Nasdaq Capital Market; no obligation to sell any shares.
- Shares to be issued under new S-3 registration statement filed December 29, 2025, pending SEC effectiveness.

## SEC filing metadata
- accession: 0001062993-25-017492
- form_type: 8-K
- ticker: MDCX
- cik: 0001997296
- company_name: Medicus Pharma Ltd.
- filed_at: 2025-12-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1997296/000106299325017492/0001062993-25-017492-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1997296/000106299325017492/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-25-017492
- JSON: https://secwatch.observer/filing/0001062993-25-017492.json
- Plain text: https://secwatch.observer/filing/0001062993-25-017492.txt

## Key facts
- Material Agreements
  Medicus Pharma Ltd. entered into Equity Distribution Agreement with Maxim Group LLC and Yorkville Securities, LLC valued at up to $15,349,674 (effective 2025-12-29).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Maxim Group LLC and Yorkville Securities, LLC
  - Value: up to $15,349,674
  - Effective: 2025-12-29
  source text: On December 29, 2025, Medicus Pharma Ltd. (the "Company") entered into an Equity Distribution Agreement (the "Agreement") with Maxim Group LLC ("Maxim") and Yorkville Securities, LLC ("Yorkville Securities" and together with Maxim, the "Agents") to create an at-the-market equity program.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1997296/000106299325017492/0001062993-25-017492-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.